Table 3 Basic data and 2 × 2 comparisons to detect the strongest human leukocyte antigen association of the risk factors a
From: HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population
A*02 | B*51 | BD patients | Controls | |||
+ | + | 72 | 29 | |||
+ | – | 76 | 112 | |||
– | + | 45 | 11 | |||
– | – | 73 | 161 | |||
A*24 | B*51 | |||||
+ | + | 26 | 6 | |||
+ | – | 36 | 30 | |||
– | + | 91 | 34 | |||
– | – | 119 | 237 | |||
B*57 | B*51 | |||||
+ | + | 8 | 0 | |||
+ | – | 24 | 11 | |||
– | + | 111 | 40 | |||
– | – | 131 | 262 | |||
Factor 1-B*51 | A*02 | A*24 | B*57 | |||
P c | OR | P c | OR | P c | OR | |
Test 1 | >0.05 | 0.62 | >0.05 | 1.54 | >0.05 | 6.17 |
Test 2 | >0.05 | 1.49 | 0.008 | 2.38 | <0.0006 | 4.25 |
Test 3 | <0.0006 | 5.40 | <0.0006 | 8.10 | 0.0012 | 33.9 |
Test 4 | <0.0006 | 0.17 | >0.05 | 0.45 | >0.05 | 0.77 |